26th Annual Summer Seminars: Emerging Strategies in the Assessment and Treatment of Depression and Anxiety: Integrating Psychopharmacology and Psychotherapy
Russell G. Vasile, MD
The objective of this seminar is to familiarize the clinician with emerging strategies in the assessment and treatment of major depression, bipolar illness and anxiety disorders. The course will also highlight key comorbid conditions associated with mood and anxiety disorders, including axis II personality disorders, management of patients with medical conditions and management of the geriatric patient. An essential theme of the seminar will be formulating an integrated psychopharmacologic and psychotherapeutic treatment approach. The psychotherapy of the mood and/or anxiety disorder patient, including those with comorbid personality disorder will be examined in detail. Issues around the choice of specific antidepressants, mood stabilizers and anti-anxiety medications and psychopharmacologic management of the treatment resistant patient will be highlighted with a discussion of the use of augmenting medication strategies and combinations of psychopharmacologic agents. Psychotherapeutic approaches to mood and anxiety disorders will be studied with a focus on differing strategies including psychodynamic psychotherapy, cognitive and behavioral therapy, interpersonal psychotherapy for depression and other psychotherapeutic approaches. The seminar will update the clinician on recent developments in neuropsychiatry, including brain imaging and therapeutic stimulation techniques.
Emerging issues in the assessment and treatment of depression and anxiety disorders will be discussed including the new DSM V diagnosis of Complication Grief Disorder, head trauma and post concussive syndrome as it relates to depression and suicide risk, and new developments in the integration of cognitive behavioral therapy and pharmacotherapy for generalized anxiety disorder in geriatric patients.
- Evaluate emerging strategies in the use of psychotropic medications in the treatment of major depression and anxiety disorders and integrate psychopharmacologic treatments into patient care;
- Integrate psychodynamic assessment, psychotherapy and psychopharmacology into the management
of depression and anxiety disorders;
- Describe strategies for the psychopharmacological and psychotherapeutic management of treatment resistant depression;
- Evaluate new developments in the treatment of depression in bipolar patients;
- Describe an evidence based approach to suicide risk assessment and prevention of suicide;
- Develop psychopharmacologic management strategies for geriatric depression and anxiety including in patients with cognitive deficits;
- Determine the specific role for vigorous exercise in the treatment of mood disorders;
- Evaluate emerging brain stimulation antidepressant treatment techniques, including trans-cranial magnetic stimulation;
- Describe new psychopharmacological and psychotherapeutic techniques in the treatment of PTSD;
- Discuss the treatment of depression and anxiety in patients with personality disorders including Borderline Personality Disorder;
- Explore the role of novel enhancements to treatment of mood disorders including omega-3 fatty acids, 1-methylfolate and zinc.
Warning: Invalid argument supplied for foreach() in /nfs/c10/h13/mnt/150145/domains/continuingeducationprogram.org/html/wp-content/themes/bidmc/single-courses.php on line 110
Registration: 8:30 am
Seminar Format: Monday – Friday: 9:00 am – 12:15 pm
Beth Israel Deaconess Department of Psychiatry Foundation, Inc./Contact Hours: 15
PHYSICIANS: The Harvard Medical School is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
The Harvard Medical School designates this live activity for a maximum of 15 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Weeklong Seminar: A maximum of 15 AMA PRA Category 1 Credits™
Weekend Seminar: A maximum of 10 AMA PRA Category 1 Credits™
THE ROYAL COLLEGE OF PHYSICIANS AND SURGEONS OF CANADA recognizes conferences and workshops held outside of Canada that are developed by a university, academy, hospital, specialty society or college as accredited group learning activities.
AMA PRA Category 1 Credits™ claimed by physicians attending live events certified and organized in the United States for AMA PRA Category 1 Credits™ can be claimed through the agreement on mutual recognition of credits between UEMS and AMA, considered as being equal to the EUROPEAN CONTINUOUS MEDICAL EDUCATION CREDITS(ECMEC©) granted by the UEMS. One AMA PRA Category 1 Credit™ is equivalent to one (1) hour of European EACCME Credit (ECMEC©), therefore up to 15 ECMEC© Credits are available. Each medical specialist should claim only those hours of credit that he/she actually spent in the educational activity.
PSYCHOLOGISTS: The Continuing Education Program at Beth Israel Deaconess Medical Center, a major teaching hospital of Harvard Medical School is approved by the American Psychological Association to offer continuing education for psychologists. The Continuing Education Program at Beth Israel Deaconess Medical Center, a major teaching hospital of Harvard Medical School maintains responsibility for this program and its content.
COUNSELORS: The Continuing Education Program at Beth Israel Deaconess Medical Center, a major teaching hospital of Harvard Medical School continuing education is an NBCC Approved Continuing Provider (ACEP) and may offer NBCC approved clock hours for events that meet NBCC requirements. The Week-Long Summer Seminars for a maximum of 15 clock hours and the Weekend Summer Seminars for a maximum of 10 clock hours. The ACEP solely is responsible for all aspects of the program.
SOCIAL WORKERS: For information on the status of the application to the Massachusetts Chapter of the National Association of Social Workers, please call 617-754-1265 or email: firstname.lastname@example.org.
NURSES: The following program have been approved by the Massachusetts Association of Registered Nurses Inc. an accredited approver by the American Nurses Credentialing Center’s Commission on Accreditation.
Russell G. Vasile, MD is an Associate Professor of Psychiatry, Harvard Medical School and Director of the Affective Disorders Consultation Program at the Beth Israel Deaconess Medical Center. Dr. Vasile has published in diverse areas related to the assessment and treatment of anxiety and affective disorders. Dr. Vasile is a graduate of the Boston Psychoanalytic Society and Institute, and is certified in Forensic Psychiatry. He is a past recipient of the Elvin V. Semrad Award for Excellence in Teaching at the Massachusetts Mental Health Center.